About: Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 1996 (uk) article scientifique publié en 1996 (fr) im Oktober 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 1996 (ast) scientific article published on 01 October 1996 (en)
publication date	wds:Q71843734-46815801-82B2-4BB9-8FC9-6424C5E35FDF
publication date	1996-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71843734-493773EB-D75B-45B7-B406-31E5DCDD8590
language of work or name	English
cites work	wds:Q71843734-0264EC49-B838-4F92-854C-CFFCC8FB8EE4 wds:Q71843734-0FA1EDAB-ADD0-4027-A057-BE1362DF5EC5 wds:Q71843734-150CAB7B-6E6C-42B8-9CDE-F589E62A583E wds:Q71843734-21C97A70-A3A2-47CE-A016-AAAFFDE0543D wds:Q71843734-23C6CA62-3E5D-40FA-849A-29D725F025F6 wds:Q71843734-306B4A59-2633-48AD-AE07-FA775860A1B5 wds:Q71843734-3BBFF3BC-48AB-4C3B-AE6E-F4E74E85858A wds:Q71843734-3C28E648-C804-4F32-AB52-BCF653AA79A6 wds:Q71843734-3D9C990F-D899-401E-BECF-C36E8E71A6C1 wds:Q71843734-44E49F6E-FFD6-4FB8-B9FA-BEFBD72C283E wds:Q71843734-4F9692E5-D7C1-4EC4-B9BC-03FBE87B82CA wds:Q71843734-58EFEF6C-F469-4094-9CA0-53FF10B0A573 wds:Q71843734-5DC48CCB-201A-4DE1-AC93-38E988DAC12C wds:Q71843734-6EEBF292-048F-4DF3-8FDC-450E9857C912 wds:Q71843734-8DFFFDCF-6692-40AB-A039-5AA92AF3FA55 wds:Q71843734-9B6400F1-62BB-4E0E-804D-797C0FF49C27 wds:Q71843734-9CFDCA82-0552-4F3A-B773-E507F68E2D96 wds:Q71843734-9FEE6B4B-1F5C-44FF-B269-696989B75A25 wds:Q71843734-AA3436CA-1851-43D4-913F-027FEBE9EDA1 wds:Q71843734-AFE74E1F-3CD0-44EE-8F43-DD767FFB0DB1 wds:Q71843734-B94D07AC-6545-4DD5-8760-82679F030F01 wds:Q71843734-BF1EA43E-F1EA-4119-9241-F561234ED291 wds:Q71843734-C253FC2B-36C5-450E-9D61-5407A8C24126 wds:Q71843734-D44388D4-929C-4AF6-B806-155C9F464EEB wds:Q71843734-DF9CB336-DB6C-4AA4-970D-30CD6CF9C85B wds:Q71843734-E1B6F818-3A01-4829-99FC-5B2B155DE4F4 wds:Q71843734-E6E3E816-EDE3-41C4-982D-7AF1B942814A wds:Q71843734-E81CCA2E-4CDA-48E0-A9FB-5AF7DA6471E1 wds:Q71843734-FE54E44F-175B-469F-B68E-668C218D4E53 wds:Q71843734-FE95E353-3FD7-4732-BBAD-ABF99A362AC9
cites work	Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome Prostate-specific antigen to determine progression-free survival after radiation therapy for localized carcinoma of prostate Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: prognostic implications Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy. Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer Prostatic-specific antigen doubling times in patients with prostate cancer: a potentially useful reflection of tumor doubling time Nonparametric Estimation from Incomplete Observations The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. Prostate Specific Antigen in the Management of Patients with Localized Adenocarcinoma of the Prostate Treated with Primary Radiation Therapy Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome The value of serum prostate specific antigen determinations before and after radical prostatectomy Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapy. Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate. Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy. Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications Prostate-specific antigen and radiation therapy for clinically localized prostate cancer Radical prostatectomy and radical radiation therapy for clinical stages T1 to 2 adenocarcinoma of the prostate: new insights into outcome from repeat biopsy and prostate specific antigen followup. Biopsy after External Beam Radiation Therapy for Adenocarcinoma of the Prostate: Correlation with Original Histological Grade and Current Prostate Specific Antigen Levels Prostate specific antigen after external beam radiotherapy for prostatic cancer: followup. Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer Cancer Control following Anatomical Radical Prostatectomy: An Interim Report Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer Prostate-specific antigen decline: a major prognostic factor for prostate cancer treated with radiation therapy Serum prostate-specific antigen in monitoring the response of carcinoma of the prostate to radiation therapy The prognostic significance of a single serum prostate-specific antigen value beyond six months after radiation therapy for adenocarcinoma of the prostate Do prostatic biopsies 12 months or more after external irradiation for adenocarcinoma, Stage III, predict long-term survival?
author name string	wds:Q71843734-1189E040-A0E6-45E2-894C-1F492836A318 wds:Q71843734-2C0050E2-30FC-44A3-ACDB-939E0BA2A8BB wds:Q71843734-3A017BAD-3AA7-4582-8D1D-A39421C329F9 wds:Q71843734-638F681C-8195-4195-8911-398B75752E44 wds:Q71843734-6A7D572A-EDE5-437B-912F-F03D379F446B wds:Q71843734-6B9AB325-539E-46F3-8B59-6CDCB04739F7 wds:Q71843734-8A8448F8-09FF-4051-A0F6-CE7A25639245 wds:Q71843734-8FCA98E8-BF2A-491C-A747-9B02C6811662 wds:Q71843734-B1978370-2A26-41B4-89C2-A97C287ACF8E wds:Q71843734-E6BF0B06-5ABD-4E33-8968-8DD69776F80E
author name string	E M Horwitz J S Stromberg P Y Chen J Gonzalez J Hollander A A Martinez E L Ziaja F A Vicini C F Dmuchowski D S Brabbins
rdfs:label	Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control (en) Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control (nl)
skos:prefLabel	Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control (en) Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control (nl)
name	Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control (en) Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control (nl)
title	wds:Q71843734-A8939667-908D-4581-A921-019353DCEF6E
title	Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control (en)
page(s)	wds:Q71843734-6317495F-6D14-44D0-AE20-9B311F5B9427

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software